Psychedelics Small Pharma acquires U.S. patent for its DMT compounds The company has enhanced its IP portfolio with a patent that will be valid until 2041 Rowan DunneOctober 21, 2022
International Psychedelic drugs market awaits nearly 100% revenue expansion by 2026 end: Fairfield The market researcher anticipates a 14.5% CAGR during the 2021-2026 forecast period Rowan DunneOctober 20, 2022
International European Psychiatric Association aligns with PAREA: a multi-organization psychedelic partnership The new member organization consists of over 78,000 psychiatrists Rowan DunneOctober 17, 2022
Canada Alberta pioneers psychedelic therapy regulations in Canada New amendment to the Mental Health Services Protection Regulation has been initiated to effectively safeguard patients Rowan DunneOctober 6, 2022
Psychedelics People are taking large doses of psychedelics to treat pain: survey study Although the effects were weaker and more prone to bias, microdoses also seemed to be efficient in pain management Natalia Buendia CalvilloOctober 6, 2022
Psychedelics Numinus develops psilocybin-infused tea bag for clinical studies The company plans to use mushroom tea to treat patients pending regulatory approvals Rowan DunneOctober 5, 2022
Psychedelics Choose Ketamine now offering at-home treatments in several states Company intends to provide ketamine therapy at a much lower price than a visit to the clinic would cost Rowan DunneOctober 4, 2022
Psychedelics Silo Pharma prepares pre-IND package for FDA on novel ketamine formulation Company will collaborate with Premier Consulting as regulatory partner and utilize Zylö Therapeutics Z-Pod technology Rowan DunneOctober 3, 2022
Canada Vancouver mushroom dispensaries continue to operate in legal grey area These relatively new stores remind people about the final days of the cannabis prohibition era in Canada Rowan DunneOctober 3, 2022
Psychedelics Psyence sends psilocybin mushrooms to Psilo Pharma in Portugal Shipment marks company's first successful export to Europe and second to date Rowan DunneSeptember 29, 2022